About: Dyne Therapeutics, Inc., a clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States. The company is developing a portfolio of muscle disease therapeutics, including programs in myotonic dystrophy type 1; duchenne muscular dystrophy; facioscapulohumeral dystrophy; and Pompe disease, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its FORCE platform that delivers disease-modifying therapeutics. Dyne Therapeutics, Inc. was incorporated in 2017 and is headquartered in Waltham, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $15.41 (-3.45%)
DYN NASDAQ Dyne Therapeutics Inc
Dyne Therapeutics Inc share price
DYN price activity
Last Price
$15.410
Change (24hr)
-0.55 USD (-3.45%)
Volume
1.45M
Volume (4w avg)
-
Open
$15.97
Day Range
$15.41 - $15.97
Previous Close
$15.96
Last Trade
13 Oct, 6:02 pm GMT+0
Delayed
13 Oct, 6:02 pm GMT+0
DYN price performance
Delayed
13 Oct, 6:02 pm GMT+0
DYN Market Signals